Stock Fundamentals

Company Information

▼
Company Name
Nuvectis Pharma Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US67080T1088
CIK: 0001875558
CUSIP: 67080T108
Currency: USD
Full Time Employees: 13
Phone: 201 614 3150
Website: https://www.nuvectis.com
Fiscal Year End: December
IPO Date: Feb 04, 2022
Description:

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.

Address:

1 Bridge Plaza, Fort Lee, NJ, United States, 07024

Directors & Officers

▼
Name Title Year Born
Mr. Ron Bentsur M.B.A. Co-Founder, Chairman, CEO & President 1966
Dr. Enrique Poradosu Ph.D. Co-Founder, Executive VP, Chief Scientific & Business Officer 1967
Mr. Shay Shemesh Co-Founder, Executive VP, Chief Development & Operations Officer 1984
Mr. Michael Carson CPA Vice President of Finance 1977

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 845.50K Dec 31, 2025 3.19% $0.00 21.01%
BlackRock Inc 685.34K Sep 30, 2025 2.59% $0.00 6.59%
Iridian Asset Management LLC 586.32K Dec 31, 2025 2.21% $1.63 44.55%
Baldwin Brothers Inc 389.63K Dec 31, 2025 1.47% $0.19 11.18%
Occam Crest Management L.P. 380.00K Dec 31, 2025 1.43% $1.99 31.03%
Geode Capital Management, LLC 325.73K Sep 30, 2025 1.23% $0.00 14.16%
State Street Corp 136.72K Sep 30, 2025 0.52% $0.00 20.37%
Northern Trust Corp 106.64K Sep 30, 2025 0.40% $0.00 -2.89%
Susquehanna International Group, LLP 90.88K Sep 30, 2025 0.34% $0.00 100.73%
Oppenheimer & Co Inc 73.57K Dec 31, 2025 0.28% $0.01 6.52%
Forbes J M & Co 59.00K Dec 31, 2025 0.22% $0.04 0.00%
The Goldman Sachs Group Inc 45.16K Sep 30, 2025 0.17% $0.00 0.00%
Charles Schwab Investment Management Inc 44.02K Dec 31, 2025 0.17% $0.00 15.90%
Royal Bank of Canada 31.01K Sep 30, 2025 0.12% $0.00 -50.36%
Bank of New York Mellon Corp 28.07K Sep 30, 2025 0.11% $0.00 3.05%
Jane Street Group LLC 26.28K Sep 30, 2025 0.10% $0.00 0.00%
UBS Group AG 25.47K Sep 30, 2025 0.10% $0.00 148.28%
Austin Wealth Management LLC 20.13K Dec 31, 2025 0.08% $0.03 0.00%
Morgan Stanley - Brokerage Accounts 18.52K Sep 30, 2025 0.07% $0.00 -25.01%
Barclays PLC 18.43K Sep 30, 2025 0.07% $0.00 -20.49%

Shares Statistics

▼
Shares Outstanding: 26.49M
Shares Float: 15.49M
% Insiders: 4,158.70%
% Institutions: 1,714.50%
Short % Float: 10.63%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Group Inc 845.50K 3.19% ▲ 21.01% Dec 31, 2025
2 BlackRock Inc 685.34K 2.59% ▲ 6.59% Sep 30, 2025
3 Iridian Asset Management LLC 586.32K 2.21% ▲ 44.55% Dec 31, 2025
4 Baldwin Brothers Inc 389.63K 1.47% ▲ 11.18% Dec 31, 2025
5 Occam Crest Management L.P. 380.00K 1.43% ▲ 31.03% Dec 31, 2025
6 Geode Capital Management, LLC 325.73K 1.23% ▲ 14.16% Sep 30, 2025
7 State Street Corp 136.72K 0.52% ▲ 20.37% Sep 30, 2025
8 Northern Trust Corp 106.64K 0.40% ▼ 2.89% Sep 30, 2025
9 Susquehanna International Group, LLP 90.88K 0.34% ▲ 100.73% Sep 30, 2025
10 Oppenheimer & Co Inc 73.57K 0.28% ▲ 6.52% Dec 31, 2025

Valuation Metrics

▼
Enterprise Value: $203.61M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $234.72M
Book Value: $0.72
Earnings/Share: $-1.32
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -68.50%
ROE (TTM): -188.03%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 2.38x 0.00x 0.42x N/A 0.00x
2024-12-31 2.09x 0.00x 0.48x N/A 0.00x
2023-12-31 2.75x 0.00x 0.36x N/A 0.00x
2022-12-31 3.30x 0.00x 0.30x -129.09x 0.00x
2021-12-31 2.41x 0.00x 2.65x -3,223.50x 0.00x
2020-12-31 583.30x 0.00x 0.00x N/A 0.00x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Nov 05, 2025 Juan Sanchez N/A Purchase 13.00K $5.79 $75.27K
Nov 05, 2025 Matthew L Kaplan N/A Purchase 11.00K $5.84 $64.24K
Nov 05, 2025 Ron Bentsur N/A Purchase 5.00K $5.72 $28.60K
Oct 27, 2025 Marlio Charles Mosseri N/A Purchase 72.84K $6.28 $457.41K
Oct 24, 2025 Marlio Charles Mosseri N/A Purchase 35.03K $6.15 $215.46K
Oct 23, 2025 Marlio Charles Mosseri N/A Purchase 46.90K $6.06 $284.21K
Jun 20, 2025 Marlio Charles Mosseri N/A Purchase 5.60K $7.99 $44.77K
Jun 18, 2025 Marlio Charles Mosseri N/A Purchase 28.04K $8.05 $225.75K
Jun 17, 2025 Marlio Charles Mosseri N/A Purchase 5.40K $8.11 $43.79K
May 12, 2025 Marlio Charles Mosseri N/A Purchase 21.17K $8.11 $171.66K
May 08, 2025 Marlio Charles Mosseri N/A Purchase 2.65K $8.65 $22.92K
May 06, 2025 Marlio Charles Mosseri N/A Purchase 12.44K $8.59 $106.89K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about NVCT.US!